Number of Shares
460,305.00
Current Holdings Value*
kr30.66 Mil
% of Portfolio
3.81%
Total Estimate Gain
kr-133.89 Mil
% of Total Estimate Gain
-41.14%

NYLI PineStone International Equity Fund's Novo Nordisk AS Holding Summary

As of 2025-04-30, NYLI PineStone International Equity Fund held 460,305.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr30.66 Mil. This investment constitutes 3.81% of their stock portfolio, and NYLI PineStone International Equity Fund now holds 0.01% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2023Q4. And since then NYLI PineStone International Equity Fund has made 5 purchases of OCSE:NOVO B, at an average price of kr705.46, for a total of 461,305.00 shares. In addition, there have been 1 sales at an average price of kr703.58 for 1,000.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr414.60, NYLI PineStone International Equity Fund's estimated gain on his OCSE:NOVO B holdings is kr-133.89 Mil, reflecting a -41.14% gain to date.

NYLI PineStone International Equity Fund OCSE:NOVO B (kr414.60) Holding Chart

NYLI PineStone International Equity Fund OCSE:NOVO B (kr414.60) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1